• OPEN AN ACCOUNT
Indian Indices
Nifty
26,033.75 47.75
(0.18%)
Sensex
85,684.74 419.42
( 0.49%)
Bank Nifty
59,288.70 -59.55
( -0.10%)
Nifty IT
38,360.25 535.00
( 1.41%)
Global Indices
Nasdaq
47,874.44 -29.46
(-0.06%)
Dow Jones
6,878.17 7.45
(0.11%)
Hang Seng
50,440.45 -587.97
(-1.15%)
Nikkei 225
9,722.32 30.25
(0.31%)
Forex
USD-INR
90.13 0.27
(0.30%)
EUR-INR
105.04 0.70
(0.67%)
GBP-INR
119.76 1.10
(0.93%)
JPY-INR
0.58 0.00
(0.57%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
100.5174369
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
44.91
42509.06
EPS(TTM)
Face Value()
Div & Yield %
55.87
10
2.15
 

As on: Dec 05, 2025 01:53 PM

Last Price() Net Change (%) Volume (Nos) P / E
2,568.20 58.90 2470 44.91
Stock Price Details
Open Price() 2,508.35
Best Buy () 2562.55
Best Sell () 2566.9
Buy Quantity (Nos) 6
Sell Quantity (Nos) 1
Today's High () 2,576.20
Today's Low () 2,508.35
52-Week High () 3515.95
152-Week Low () 1924.3
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 2.15
Eps 55.87
Book Value 100.5174369
Market Cap (.Cr) 42,509.06
Face Value 10
Market Lot 1
AGM Date Jun
Book Closure Date
ISIN No. INE159A01016


News
Indices tumble in early trade; breadth weak
Glaxosmithkline Pharmaceuticals consolidated net profit rises 1.98% in the September 2025 quarter
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Press Release
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Outcome of Board Meeting
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Investor Presentation
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Outcome of Board Meeting
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
GlaxoSmithKline Pharmaceuticals schedules board meeting
Glaxosmithkline Pharmaceuticals Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Trading Window
More
Corporate Details
Incoporation Year   : 1924
Chairman : Renu S Karnad
Bussiness Group : MNC Asc-Glaxo
Registered Office
Glaxosmithkline Pharmaceuticals Ltd
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-022-24959595
Fax:91-022-24959494
Fax:91-22-66317458
E-Mail : askus@gsk.com; ajay.a.nadkarni@gsk.com
URL : http://www.gsk-india.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Midcap
  • CNX 500
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi